Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C
Fernández A, Vázquez S, Rodríguez-González L,. Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 2008; 22: 1389-1391.
Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C
Farshidi D, Chiu MW,. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. J Am Acad Dermatol 2010; 62: 164-165.
Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: A case report
de Moraes PC, Noce CW, Thomaz LA, et al. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. J Am Dent Assoc 2009; 140: 1377-1379.
Tongue and skin hyperpigmentation during PEG-interferon-α/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C
DOI 10.1111/j.1572-0241.2005.00323.x
Gurguta C, Kauer C, Bergholz U, et al. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006; 101: 197-198. (Pubitemid 43381730)
Tongue hyperpigmentation in a Caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy [12]
DOI 10.1111/j.1572-0241.2007.01162.x
Torres HA, Bull L, Arduino RC, Barnett BJ,. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol 2007; 102: 1334-1335. (Pubitemid 46802016)